Lv31
360 积分 2022-09-27 加入
Value of tumor size as a prognostic factor in metastatic colorectal cancer patients after chemotherapy: a population-based study
20分钟前
待确认
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
2小时前
已完结
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
1个月前
已完结
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
2个月前
已完结
A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer – The FALUCA study
2个月前
已完结
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic Non‒Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial
2个月前
已完结
Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease
2个月前
已完结
Anti-VEGF Molecular Targeted Therapies in Common Solid Malignancies: Comprehensive Update for Radiologists
2个月前
已完结
Delayed immune thrombocytopenia after discontinuation of nivolumab therapy: A case report and literature review
3个月前
已完结
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial
3个月前
已完结
皖公网安备34019202002308
